CDX 0.00% 5.9¢ cardiex limited

Ann: Cardiex's inHealth Executes Major Co-Marketing Agreement, page-10

  1. 48,997 Posts.
    lightbulb Created with Sketch. 550
    Agree, these guys will be no slouches in getting traction with the company this year. This is the trans formative year we will see the value for shareholders increase.

    Last year was all about getting the pieces of the puzzle together, this year is all about execution as we saw late last year with a flurry of announcements, i do not expect them to stop IMO

    Plenty of news flow to come this quarter.

    A 10 cent valuation equates to roughly $60 mil market cap.

    If we compare the likes of RHT with there recently approved FDA approval ( which we already have for SphygmoCor )

    Then there is no reason we should not be at least 6-7 cents.

    But given what else we have on the radar as pointed out in the company overview, there is just far to much potential here for it to be sitting around current levels

    $50-60 mil market cap seems reasonable. IMO
 
watchlist Created with Sketch. Add CDX (ASX) to my watchlist
(20min delay)
Last
5.9¢
Change
0.000(0.00%)
Mkt cap ! $17.35M
Open High Low Value Volume
5.9¢ 5.9¢ 5.9¢ $1.497K 25.37K

Buyers (Bids)

No. Vol. Price($)
2 107107 5.6¢
 

Sellers (Offers)

Price($) Vol. No.
5.9¢ 10753 1
View Market Depth
Last trade - 15.48pm 30/07/2024 (20 minute delay) ?
CDX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.